1 minggu yang lalu
Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB - Get Free Report) person been fixed a statement standing of "Moderate Buy" by nan 8 brokerages that are covering nan firm, MarketBeat Ratings reports. One investigation expert has rated nan banal pinch a waste rating, six person assigned a buy…
This communicative appeared connected marketbeat.com, 2024-10-27 07:14:42.
English (US) · 
Indonesian (ID) ·